북미의 2-WAY 폴리 카테터 시장 규모, 점유율 및 동향 분석 보고서 : 적응증별, 사용 형태별, 재료별, 최종 용도별, 부문별 예측(2026-2035년)

North America 2-way Foley Catheter Market Summary

The North America 2-way foley catheter market size was estimated at USD 251.20 million in 2025 and is projected to reach USD 455.92 million by 2035, growing at a CAGR of 6.14% from 2026 to 2035. The market growth is primarily driven by the rising prevalence of urological disorders, including benign prostatic hyperplasia, urinary incontinence, chronic kidney disease, and prostate cancer.

The expanding geriatric population in the U.S. and Canada further increases the need for short- and long-term catheterization. In addition, growing surgical procedures and hospital admissions support sustained demand for urinary drainage solutions. Technological advancements such as silicone-based and antimicrobial-coated catheters also contribute to market growth by enhancing infection prevention and patient safety.

The increasing prevalence of urological diseases is a major driver for the North America 2-way foley catheters industry. The growing cases of urinary incontinence, enlarged prostate gland/benign prostatic hyperplasia, spinal cord injury, chronic kidney disease, and bladder dysfunction are significantly increasing the need for both short- and long-term catheterization. The expanding geriatric population in the U.S. and Canada, which is more prone to these conditions, further strengthens demand. Consequently, rising urological procedures and hospital admissions are supporting sustained regional market growth.

The rising prevalence of spinal cord injuries in North America contributes significantly to the demand for 2-way foley catheters, as many patients develop neurogenic bladders requiring long-term urinary drainage. This sustained need for chronic catheterization supports consistent product utilization and drives market growth, particularly in rehabilitation and long-term care settings. For instance, according to the United Spinal Association, in September 2025, an estimated 250,000 to 390,000 Americans were living with a spinal cord injury, with approximately 18,000 new cases reported annually, reflecting a significantly increasing patient population requiring ongoing medical management and supportive care.

North America 2-way Foley Catheters Market Report Segmentation

This report forecasts revenue growth at the regional and country levels and provides an analysis of the latest industry trends and opportunities in each of the sub-segments from 2018 to 2035. For this study, Grand View Research has segmented the North America 2-way Foley catheters market report based on material, indication, usage type, end use, and country:

• Material Outlook (Revenue, USD Million, 2018 - 2035)
• Silicone 2-way Foley Catheters
  • Hydrophilic Coated
  • Hydrogel Coated
  • Anti-Microbial Coated
  • Others
• Latex 2-way Foley Catheters
  • Hydrophilic Coated
  • Hydrogel Coated
  • Silicone Elastomer Coated
  • Anti-Microbial Coated
  • Others
• Indication Outlook (Revenue, USD Million, 2018 - 2035)
• Urinary Incontinence
• Enlarged Prostate Gland/BPH
• Spinal Cord Injury
• Others
• Usage Type Outlook (Revenue, USD Million, 2018 - 2035)
• Short-Term Use
• Long-Term Use
• End Use Outlook (Revenue, USD Million, 2018 - 2035)
• Hospitals
• Ambulatory Surgical Centers (ASCs)
• Long-Term Care (LTCs)
• Home Care
• Others
• Country Outlook (Revenue, USD Million, 2018 - 2035)
• U.S.
• Canada
• Mexico

Table of Contents

Chapter 1. Methodology and Scope

• 1.1. Market Segmentation and Scope
• 1.2. Segment Definitions
  • 1.2.1. Material
  • 1.2.2. Indication
  • 1.2.3. Usage Type
  • 1.2.4. End Use
  • 1.2.5. Country scope
  • 1.2.6. Estimates and forecasts timeline
• 1.3. Research Methodology
• 1.4. Information Procurement
  • 1.4.1. Purchased database
  • 1.4.2. GVR's internal database
  • 1.4.3. Secondary sources
  • 1.4.4. Primary research
  • 1.4.5. Details of primary research
• 1.5. Information or Data Analysis
  • 1.5.1. Data analysis models
• 1.6. Market Formulation & Validation
• 1.7. Model Details
  • 1.7.1. Commodity flow analysis (Model 1)
  • 1.7.2. Approach 1: Commodity flow approach
  • 1.7.3. Volume price analysis (Model 2)
  • 1.7.4. Approach 2: Volume price analysis
• 1.8. List of Secondary Sources
• 1.9. List of Primary Sources
• 1.10. Objectives

Chapter 2. Executive Summary

• 2.1. Market Outlook
• 2.2. Segment Outlook
• 2.3. Country outlook
• 2.4. Competitive Insights

Chapter 3. North America 2-way Foley Catheters Market Variables, Trends & Scope

• 3.1. Market Lineage Outlook
  • 3.1.1. Parent Market Outlook
  • 3.1.2. Related/ancillary market outlook
• 3.2. Market Dynamics
  • 3.2.1. Market Driver Analysis
    • 3.2.1.1. Introduction of Innovative and Advanced Products
    • 3.2.1.2. Increasing Prevalence of Urological and Kidney Diseases
    • 3.2.1.3. Shift from Untreated to Silicone-Based Catheters
    • 3.2.1.4. Preference for Silicone vs. Latex-Based Catheters
  • 3.2.2. Market Restraint Analysis
    • 3.2.2.1. High Cost of Silicone Catheters
    • 3.2.2.2. Stringent Regulatory Requirements
    • 3.2.2.3. Increasing Focus on CAUTI Prevention Protocols
  • 3.2.3. Market Opportunity Analysis
    • 3.2.3.1. Growing Clinical Trials and Studies Focused on Urinary Catheters
    • 3.2.3.2. Expansion of Home Healthcare Settings
    • 3.2.3.3. CAUTI Prevention Initiatives and Value-Based Reimbursement
    • 3.2.3.4. Development of Value-Added Features
    • 3.2.3.5. Rising Investments & Funding for Research Activities
    • 3.2.3.6. Growing Geriatric Population
  • 3.2.4. Market Challenge Analysis
    • 3.2.4.1. Risk of CAUTI
    • 3.2.4.2. Patient Discomfort and Reduced Quality of Life
    • 3.2.4.3. Growing Emphasis on Catheter Alternatives
    • 3.2.4.4. Product Recalls
• 3.3. North America 2-way Foley Catheters Market Analysis Tools
  • 3.3.1. Industry Analysis - Porter's
    • 3.3.1.1. Bargaining Power of Suppliers
    • 3.3.1.2. Bargaining Power of Buyers
    • 3.3.1.3. Threat of Substitutes
    • 3.3.1.4. Threat of New Entrants
    • 3.3.1.5. Competitive Rivalry
  • 3.3.2. PESTEL Analysis
    • 3.3.2.1. Political Landscape
    • 3.3.2.2. Economic Landscape
    • 3.3.2.3. Social Landscape
    • 3.3.2.4. Technological Landscape
    • 3.3.2.5. Environmental Landscape
    • 3.3.2.6. Legal Landscape

Chapter 4. North America 2-way Foley Catheters Market: Indication Estimates & Trend Analysis

• 4.1. Segment Dashboard
• 4.2. North America 2-way Foley Catheters Market: Indication Movement Analysis
• 4.3. North America 2-way Foley Catheters Market by Indication Outlook (USD Million)
• 4.4. Market Size & Forecasts and Trend Analyses, 2018 to 2035 for the following
• 4.5. Urinary Incontinence
  • 4.5.1. Urinary Incontinence Market Revenue Estimates and Forecasts, 2018 - 2035 (USD Million)
• 4.6. Enlarged Prostate Gland/BPH
  • 4.6.1. Enlarged Prostate Gland/BPH Market Revenue Estimates and Forecasts, 2018 - 2035 (USD Million)
• 4.7. Spinal Cord Injury
  • 4.7.1. Spinal Cord Injury Market Revenue Estimates and Forecasts, 2018 - 2035 (USD Million)
• 4.8. Others
  • 4.8.1. Others Market Revenue Estimates and Forecasts, 2018 - 2035 (USD Million)

Chapter 5. North America 2-way Foley Catheters Market: Usage Type Estimates & Trend Analysis

• 5.1. Segment Dashboard
• 5.2. North America 2-way Foley Catheters Market: Usage Type Movement Analysis
• 5.3. North America 2-way Foley Catheters Market by Usage Type Outlook (USD Million)
• 5.4. Market Size & Forecasts and Trend Analyses, 2018 to 2035 for the following
• 5.5. Short-Term Use
  • 5.5.1. Short-Term Use Market Revenue Estimates and Forecasts, 2018 - 2035 (USD Million)
• 5.6. Long-Term Use
  • 5.6.1. Long-Term Use Market Revenue Estimates and Forecasts, 2018 - 2035 (USD Million)

Chapter 6. North America 2-way Foley Catheters Market: Material Estimates & Trend Analysis

• 6.1. Segment Dashboard
• 6.2. North America 2-way Foley Catheters Market: Material Movement Analysis
• 6.3. North America 2-way Foley Catheters Market by Material Outlook (USD Million)
• 6.4. Market Size & Forecasts and Trend Analyses, 2018 to 2035 for the following
• 6.5. Silicone 2-way Foley Catheters
  • 6.5.1. Silicone 2-way Foley Catheters Market Revenue Estimates and Forecasts, 2018 - 2035 (USD Million)
  • 6.5.2. Hydrophilic Coated
    • 6.5.2.1. Hydrophilic Coated Market Revenue Estimates and Forecasts, 2018 - 2035 (USD Million)
  • 6.5.3. Hydrogel Coated
    • 6.5.3.1. Hydrogel Coated Market Revenue Estimates and Forecasts, 2018 - 2035 (USD Million)
  • 6.5.4. Anti-Microbial Coated
    • 6.5.4.1. Anti-Microbial Coated Market Revenue Estimates and Forecasts, 2018 - 2035 (USD Million)
  • 6.5.5. Others
    • 6.5.5.1. Others Market Revenue Estimates and Forecasts, 2018 - 2035 (USD Million)
• 6.6. Latex 2-way Foley Catheters
  • 6.6.1. Latex 2-way Foley Catheters Market Revenue Estimates and Forecasts, 2018 - 2035 (USD Million)
  • 6.6.2. Hydrophilic Coated
    • 6.6.2.1. Hydrophilic Coated Market Revenue Estimates and Forecasts, 2018 - 2035 (USD Million)
  • 6.6.3. Hydrogel Coated
    • 6.6.3.1. Hydrogel Coated Market Revenue Estimates and Forecasts, 2018 - 2035 (USD Million)
  • 6.6.4. Anti-Microbial Coated
    • 6.6.4.1. Anti-Microbial Coated Market Revenue Estimates and Forecasts, 2018 - 2035 (USD Million)
  • 6.6.5. Silicone Elastomer Coated
    • 6.6.5.1. Silicone Elastomer Coated Market Revenue Estimates and Forecasts, 2018 - 2035 (USD Million)
  • 6.6.6. Others
    • 6.6.6.1. Others Market Revenue Estimates and Forecasts, 2018 - 2035 (USD Million)

Chapter 7. North America 2-way Foley Catheters Market: End Use Estimates & Trend Analysis

• 7.1. Segment Dashboard
• 7.2. North America 2-way Foley Catheters Market: End Use Movement Analysis
• 7.3. North America 2-way Foley Catheters Market by End Use Outlook (USD Million)
• 7.4. Market Size & Forecasts and Trend Analyses, 2018 to 2035 for the following
• 7.5. Hospitals
  • 7.5.1. Hospitals Market Revenue Estimates and Forecasts, 2018 - 2035 (USD Million)
• 7.6. Long-Term Care Facilities (LTCs)
  • 7.6.1. Long-Term Care (LTCs) Market Revenue Estimates and Forecasts, 2018 - 2035 (USD Million)
• 7.7. Home Care
  • 7.7.1. Home Care Market Revenue Estimates and Forecasts, 2018 - 2035 (USD Million)
• 7.8. Ambulatory Surgery Centers (ASCs)
  • 7.8.1. Ambulatory Surgery Centers (ASCs) Market Revenue Estimates and Forecasts, 2018 - 2035 (USD Million)
• 7.9. Others
  • 7.9.1. Others Market Revenue Estimates and Forecasts, 2018 - 2035 (USD Million)

Chapter 8. North America 2-way Foley Catheters Market: Country Estimates & Trend Analysis, by Material, by Usage Type, by Indication, and by End Use

• 8.1. Country Dashboard
• 8.2. Country 2-way Foley Catheters Market Movement Analysis & Market Share, 2025 & 2035
• 8.3. North America 2-way Foley Catheters Market: Country Estimates & Trend Analysis
• 8.4. Market Size & Forecasts and Trend Analyses, 2018 to 2035 for the following
• 8.5. North America
  • 8.5.1. North America 2-way Foley Catheters Market Estimates and Forecasts, 2018 - 2035 (USD Million)
  • 8.5.2. U.S.
    • 8.5.2.1. Key Country Dynamics
    • 8.5.2.2. Competitive Scenario
    • 8.5.2.3. Regulatory Framework
    • 8.5.2.4. Reimbursement scenario
    • 8.5.2.5. U.S. 2-way Foley Catheters Market Estimates and Forecasts, 2018 - 2035 (USD Million)
  • 8.5.3. Canada
    • 8.5.3.1. Key Country Dynamics
    • 8.5.3.2. Competitive Scenario
    • 8.5.3.3. Regulatory Framework
    • 8.5.3.4. Reimbursement scenario
    • 8.5.3.5. Canada 2-way Foley Catheters Market Estimates and Forecasts, 2018 - 2035 (USD Million)
  • 8.5.4. Mexico
    • 8.5.4.1. Key Country Dynamics
    • 8.5.4.2. Competitive Scenario
    • 8.5.4.3. Regulatory Framework
    • 8.5.4.4. Reimbursement scenario
    • 8.5.4.5. Mexico 2-way Foley Catheters Market Estimates and Forecasts, 2018 - 2035 (USD Million)

Chapter 9. Competitive Landscape

• 9.1. Market Participant Categorization
• 9.2. Company Share Analysis, 2025
• 9.3. Key Company Profiles
  • 9.3.1. BD (Bard)
    • 9.3.1.1. Company overview
    • 9.3.1.2. Financial performance
    • 9.3.1.3. Product benchmarking
    • 9.3.1.4. Strategic initiatives
  • 9.3.2. Teleflex Incorporated
    • 9.3.2.1. Company overview
    • 9.3.2.2. Financial performance
    • 9.3.2.3. Product benchmarking
    • 9.3.2.4. Strategic initiatives
  • 9.3.3. Medline Industries
    • 9.3.3.1. Company overview
    • 9.3.3.2. Financial performance
    • 9.3.3.3. Product benchmarking
    • 9.3.3.4. Strategic initiatives
  • 9.3.4. Cardinal Health
    • 9.3.4.1. Company overview
    • 9.3.4.2. Financial performance
    • 9.3.4.3. Product benchmarking
    • 9.3.4.4. Strategic initiatives
  • 9.3.5. Medtronic
    • 9.3.5.1. Company overview
    • 9.3.5.2. Financial performance
    • 9.3.5.3. Product benchmarking
    • 9.3.5.4. Strategic initiatives
  • 9.3.6. Coloplast Corp
    • 9.3.6.1. Company overview
    • 9.3.6.2. Financial performance
    • 9.3.6.3. Product benchmarking
    • 9.3.6.4. Strategic initiatives
  • 9.3.7. Amsino International, Inc.
    • 9.3.7.1. Company overview
    • 9.3.7.2. Financial performance
    • 9.3.7.3. Product benchmarking
    • 9.3.7.4. Strategic initiatives
  • 9.3.8. HR HealthCare
    • 9.3.8.1. Company overview
    • 9.3.8.2. Financial performance
    • 9.3.8.3. Product benchmarking
    • 9.3.8.4. Strategic initiatives
  • 9.3.9. Dynarex Corporation
    • 9.3.9.1. Company overview
    • 9.3.9.2. Financial performance
    • 9.3.9.3. Product benchmarking
    • 9.3.9.4. Strategic initiatives
  • 9.3.10. Sterimed Group.
    • 9.3.10.1. Company overview
    • 9.3.10.2. Financial performance
    • 9.3.10.3. Product benchmarking
    • 9.3.10.4. Strategic initiatives
  • 9.3.11. Well Lead Medical Co., Ltd.
    • 9.3.11.1. Company overview
    • 9.3.11.2. Financial performance
    • 9.3.11.3. Product benchmarking
    • 9.3.11.4. Strategic initiatives